https://www.avient.com/sites/default/files/2022-08/Humotech Robotic Prosthetic Case Study.pdf
different stiffness categories and lengths, while examining the patient’s balance
https://www.avient.com/sites/default/files/2020-12/firecon-cpe-product-bulletin.pdf
Resistant to acids, alkalis, oils, fuels and chemical solvents • Excellent balance
https://www.avient.com/sites/default/files/2022-03/Trilliant HC Electrically Conductive Formulations for Pipette Tips Application Bulletin.pdf
An outstanding balance of conductivity, flow, dimensional stability and toughness
https://www.avient.com/sites/default/files/2021-02/versaflex-non-blooming-solution-technical-bulletin.pdf
CE 3130 non-blooming series performed better than competitive materials in balancing
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Financial%2520Review.pdf
offering • End market presence AcquisitionsAcquisitions Use of Cash Current Cash Balance
https://www.avient.com/sites/default/files/2025-11/Avient November Investor Presentation - Baird Global Industrial Conference w. Non-GAAP.pdf
Invested capital is calculated using the average of total debt and equity balances
https://www.avient.com/sites/default/files/2022-02/Q4 2021 Avient Earnings Release_0.pdf
valuation allowances. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance
Sheets (Unaudited) (In millions) Year Ended December 31, 2021 2020 ASSETS Current
https://www.avient.com/sites/default/files/2021-10/avnt-q3-2021-news-release.pdf
allowance adjustments. 10 Attachment 4 Avient Corporation Condensed Consolidated Balance
Sheets (In millions) (Unaudited) September 30, 2021 December 31, 2020 ASSETS
https://www.avient.com/sites/default/files/2023-03/AVNT Mar 2023 Earnings Presentation.pdf
EBITDA $845 $3,450 Q1 FY Adjusted EPS (in millions) (in millions) CASH FLOW / BALANCE
SHEET 25 • IT investment to further integrate acquired businesses and capture
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
acquisition • Cash flow deployed to M&A, opportunistic share repurchases and balance
sheet / leverage reduction 3.5x 2.7x 2.1x 2019PF 2020PF 2021E Net Debt / Adjusted